These effects are negated when AIB1 is overexpressed, demonstrating how overexpression or amplification of AIB1 in ER+ BC supports E2-induced tumor cell proliferation in the presence of competing nuclear receptors. The gene discussed is NCOA3; the disease is breast cancer.